Regulation of cellular oxidative stress and apoptosis by G protein-coupled receptor kinase-2; The role of NADPH oxidase 4

Cellular Signalling

Volumn 28, Issue 3, 2016, Pages 190-203

  Theccanat, Tiju ^a   Philip, Jennifer L ^b   Razzaque, Abdur M ^b   Ludmer, Nicholas ^a   Li, Jinju ^a   Xu, Xianyao ^b   Akhter, Shahab A ^b  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

G protein coupled receptor kinases; Heart failure; NADPH oxidase; Oxidative stress

Indexed keywords

ACETOPHENONE DERIVATIVE; ANGIOTENSIN II; APOCYNIN; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ARRESTIN; CYBB PROTEIN, RAT; CYCLIC AMP; G PROTEIN COUPLED RECEPTOR KINASE 2; ISOPRENALINE; MEMBRANE PROTEIN; NOX4 PROTEIN, RAT; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RETINA S ANTIGEN; RHODOPSIN; SMALL INTERFERING RNA;

ANIMAL; ANTAGONISTS AND INHIBITORS; APOPTOSIS; CARDIAC MUSCLE CELL; CELL LINE; CHEMISTRY; CONFOCAL MICROSCOPY; CYTOLOGY; DRUG EFFECTS; GENETICS; HEART FAILURE; METABOLISM; MITOCHONDRION; OXIDATIVE STRESS; PATHOLOGY; PHOSPHORYLATION; RAT; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

ACETOPHENONES; ADRENERGIC BETA-AGONISTS; ANGIOTENSIN II; ANIMALS; APOPTOSIS; ARRESTINS; BETA-ARRESTINS; CELL LINE; CYCLIC AMP; G-PROTEIN-COUPLED RECEPTOR KINASE 2; HEART FAILURE; ISOPROTERENOL; MEMBRANE GLYCOPROTEINS; MICROSCOPY, CONFOCAL; MITOCHONDRIA; MYOCYTES, CARDIAC; NADPH OXIDASE; OXIDATIVE STRESS; PHOSPHORYLATION; RATS; REACTIVE OXYGEN SPECIES; RECEPTORS, ADRENERGIC, BETA; RHODOPSIN; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 84952930787     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2015.11.013     Document Type: Article

References (31)

1. Bristow M.R., Ginsburg R., Minobe W., Cubicciotti R.S., Sageman W.S., Lurie K., et al. Decreased catecholamine sensitivity and β-adrenergic receptor density in failing human hearts. N. Engl. J. Med. 1982, 307:205-211.
2. 2-adrenergic receptor subpopulations in nonfailing and failing human ventricular myocardium. Circ. Res. 1986, 59:297-309.
3. Inglese J., Freedman N.J., Koch W.J., Lefkowitz R.J. Structure and mechanism of the G protein-coupled receptor kinases. J. Biol. Chem. 1993, 268:23735-23738.
4. Patel P.A., Tilley D.G., Rockman H.A. Physiologic and cardiac roles of β-arrestins. J. Mol. Cell. Cardiol. 2009, 46:300-308.
5. Koch W.J., Rockman H.A., Samama P., Hamilton R.A., Bond R.A., Milano C.A., et al. Cardiac function in mice overexpressing the β-adrenergic receptor kinase or a βARK inhibitor. Science 1995, 268:1350-1353.
6. Rengo G., Lymperopoulos A., Zincarelli C., Donniacuo M., Soltys S., Rabinowitz J.E., et al. Myocardial adeno-associated virus serotype 6-betaARKct gene therapy improves cardiac function and normalizes the neurohormonal axis in chronic heart failure. Circulation 2009, 119:89-98.
7. Akhter S.A., Eckhart A.D., Rockman H.A., Shotwell K., Lefkowitz R.J., Koch W.J. In vivo inhibition of elevated myocardial β-adrenergic receptor kinase activity in hybrid transgenic mice restores normal β-adrenergic signaling and function. Circulation 1999, 100(6):648-653.
8. Noor N., Patel C.B., Rockman H.A. β-Arrestin: a signaling molecule and potential therapeutic target for heart failure. J. Mol. Cell. Cardiol. 2011, 51:534-541.
9. Vinge L.E., Øie E., Andersson Y., Grogaard H.K., Andersen G., Attramadal H. Myocardial distribution and regulation of GRK and beta-arrestin isoforms in congestive heart failure in rats. Am. J. Physiol. Heart Circ. Physiol. 2001, 281(6):H2490-H2499.
10. Singh K., Communal C., Sawyer D.B., Colucci W.S. Adrenergic regulation of myocardial apoptosis. Cardiovasc. Res. 2000, 45:713-719.
11. Narula J., Haider N., Virmani R., DiSalvo T.G., Kolodgie F.D., Hajjar R.J., et al. Apoptosis in myocytes in end-stage heart failure. N. Engl. J. Med. 1996, 335(16):1182-1189.
12. Whelan R.S., Kaplinskiy V., Kitsis R.N. Cell death in the pathogenesis of heart disease: mechanisms and significance. Annu. Rev. Physiol. 2010, 72:19-44.
13. 2-adrenergic signaling in adult mouse cardiac myocytes. Proc. Natl. Acad. Sci. U. S. A. 2001, 98(4):1607-1612.
14. Communal C., Singh K., Pimentel D.R., Colucci W.S. Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the beta-adrenergic pathway. Circulation 1998, 98:1329-1334.
15. Mann D.L., Kent R.L., Parsons B., Cooper G. Adrenergic effects on the biology of the adult mammalian cardiocyte. Circulation 1992, 85:790-804.
16. Octavia Y., Brunner-La Rocca H.P., Moens A.L. NADPH oxidase-dependent oxidative stress in the failing heart: from pathogenic roles to therapeutic approach. Free Radic. Biol. Med. 2012, 52:291-297.
17. Byrne J.A., Grieve D.J., Bendall J.K., Li J.M., Gove C., Lambeth J.D., et al. Contrasting roles of NADPH oxidase isoforms in pressure-overload versus angiotensin II-induced cardiac hypertrophy. Circ. Res. 2003, 93:802-805.
18. Kuroda J., Ago T., Matsushima S., Zhai P., Schneider M.D., Sadoshima J. NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart. Proc. Natl. Acad. Sci. U. S. A. 2010, 107(35):15565-15570.
19. Tetsuro A., Kuroda J., Pain J., Fu C., Li H., Sadoshima J. Upregulation of Nox4 by hypertrophic stimuli promotes apoptosis and mitochondrial dysfunction in cardiac myocytes. Circ. Res. 2010, 106:1253-1264.
20. Ide T., Tsutsui H., Hayashidani S., Kang D., Suematsu N., Nakamura L., et al. Mitochondrial DNA damage and dysfunction associated with oxidative stress in failing hearts after myocardial infarction. Circ. Res. 2001, 88:529-535.
21. Bristow M.R. Mechanism of action of beta-blocking agents in heart failure. Am. J. Cardiol. 1997, 80(11A):26L-40L.
22. Rockman H.A., Choi D.J., Akhter S.A., Jaber M., Giros B., Lefkowitz R.J., et al. Control of myocardial contractile function by the level of β-adrenergic receptor kinase 1 in gene targeted mice. J. Biol. Chem. 1998, 273(29):18180-18184.
23. Brinks H., Boucher M., Gao E., Chuprun J.K., Pesant S., Raake P.W., et al. Level of G protein-coupled receptor kinase-2 determines myocardial ischemia/reperfusion injury via pro- and anti-apoptotic mechanisms. Circ. Res. 2010, 107(9):1140-1149.
24. Cucoranu I., Clempus R., Dikalova A., Phelan P.J., Ariyan S., Dikalov S., et al. NAD(P)H oxidase 4 mediates transforming growth factor-beta 1-induced differentiation of cardiac fibroblasts into myofibroblasts. Circ. Res. 2005, 97:900-907.
25. 2-adrenergic receptors on cardiac myocyte apoptosis: role of a pertussis toxin-sensitive G protein. Circulation 1999, 100:2210-2212.
26. 2+/calmodulin kinase. J. Clin. Invest. 2003, 111:617-625.
27. Spallarossa P., Garibaldi S., Altieri P., Fabbi P., Manca V., Nasti S., Rossettin P., Ghigliotti G., Ballestrero A., Patrone F., Barsotti A., Brunelli C. Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitro. J. Mol. Cell. Cardiol. 2004, 37(4):837-846.
28. Xue W., Liu Y., Zhao J., Cai L., Li X., Feng W. Activation of HIF-1 by metallothionein contributes to cardiac protection in the diabetic heart. Am. J. Physiol. Heart Circ. Physiol. 2012, 302(12):H2528-H2535.
29. Tan Y., Li X., Prabhu S.D., Brittian K.R., Chen Q., Yin X., McClain C.J., Zhou Z., Cai L. Angiotensin II plays a critical role in alcohol-induced cardiac nitrative damage, cell death, remodeling, and cardiomyopathy in a protein kinase C/nicotinamide adenine dinucleotide phosphate oxidase-dependent manner. J. Am. Coll. Cardiol. 2012, 59(16):1477-1486.
30. Hašková P., Kovaříková P., Koubková L., Vávrová A., Macková E., Simůnek T. Iron chelation with salicylaldehyde isonicotinoyl hydrazone protects against catecholamine autoxidation and cardiotoxicity. Free Radic. Biol. Med. 2011, 50(4):537-549.
31. Chen M., Sato P.Y., Chuprun J.K., Peroutka R.J., Otis N.J., Ibetti J., Pan S., Sheu S.S., Gao E., Koch W.J. Pro-death signaling of GRK2 in cardiac myocytes after ischemic stress occurs via ERK-dependent, Hsp90-mediated mitochondrial targeting. Circ. Res. 2013, 112(8):1121-1134.